drugset / Trial / NCT02393963

Intra-articular Tranexamic Acid in the Reduction of Blood Transfusions in Primary Total Hip and Total Knee Arthroplasty

NCT02393963

Phase 2 Completed 140 enrolled Orthopaedic Innovation Centre
RandomizedParallel-groupTriple-blindPrevention

Summary

This is a randomized, double blinded, controlled trial in patients undergoing elective Total Knee Arthroplasty (TKA) and Total Hip Arthroplasty (THA). The study group will receive intra-articular Tranexamic Acid (TXA) while the control group will receive normal saline placebo.

Timeline

Start
2015-07
Primary completion
2016-07
Completion
2016-12-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 0.5 g Other

Indications